Tech Company Financing Transactions
Eagle Pharmaceuticals Funding Round
Private investors participated in a $11.7 million funding round for Eagle Pharmaceuticals. The funding round closed on 3/31/2011.
Transaction Overview
Company Name
Announced On
3/31/2011
Transaction Type
Venture Equity
Amount
$11,681,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
50 Tice Blvd. 315
Woodcliff Lake, NJ 07677
USA
Woodcliff Lake, NJ 07677
USA
Phone
Website
Email Address
Not Recorded
Overview
See how Eagle Pharmaceuticals is improving upon existing drug formulations to benefit patients and healthcare professionals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Tarriff
Chief Financial Officer
Peter Meyers
Chief Medical Officer
Adrian Hepner
President
David Pernock
VP - Bus. Development
Daniel O'Connor
Browse more venture capital transactions:
Prev: 3/31/2011: Immunome venture capital transaction
Next: 3/31/2011: Redbrick Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs